Chronic kidney disease (CKD) is a public health epidemic that increases risk of death due to cardiovascular disease. Left ventricular hypertrophy (LVH) is an important mechanism of cardiovascular disease in individuals with CKD. Elevated levels of FGF23 have been linked to greater risks of LVH and mortality in patients with CKD, but whether these risks represent causal effects of FGF23 is unknown. Here, we report that elevated FGF23 levels are independently associated with LVH in a large, racially diverse CKD cohort. FGF23 caused pathological hypertrophy of isolated rat cardiomyocytes via FGF receptor–dependent activation of the calcineurin-NFAT signaling pathway, but this effect was independent of klotho, the coreceptor for FGF23 in the kidney and parathyroid glands. Intramyocardial or intravenous injection of FGF23 in wild-type mice resulted in LVH, and klotho-deficient mice demonstrated elevated FGF23 levels and LVH. In an established animal model of CKD, treatment with an FGF–receptor blocker attenuated LVH, although no change in blood pressure was observed. These results unveil a klotho-independent, causal role for FGF23 in the pathogenesis of LVH and suggest that chronically elevated FGF23 levels contribute directly to high rates of LVH and mortality in individuals with CKD.
Christian Faul, Ansel P. Amaral, Behzad Oskouei, Ming-Chang Hu, Alexis Sloan, Tamara Isakova, Orlando M. Gutiérrez, Robier Aguillon-Prada, Joy Lincoln, Joshua M. Hare, Peter Mundel, Azorides Morales, Julia Scialla, Michael Fischer, Elsayed Z. Soliman, Jing Chen, Alan S. Go, Sylvia E. Rosas, Lisa Nessel, Raymond R. Townsend, Harold I. Feldman, Martin St. John Sutton, Akinlolu Ojo, Crystal Gadegbeku, Giovana Seno Di Marco, Stefan Reuter, Dominik Kentrup, Klaus Tiemann, Marcus Brand, Joseph A. Hill, Orson W. Moe, Makoto Kuro-o, John W. Kusek, Martin G. Keane, Myles Wolf
Title and authors | Publication | Year |
---|---|---|
Insulin suppresses the production of fibroblast growth factor 23 (FGF23)
L Bär, M Feger, A Fajol, LO Klotz, S Zeng, F Lang, B Hocher, M Föller |
Proceedings of the National Academy of Sciences | 2018 |
Fibroblast Growth Factor 23 Associates with Death in Critically Ill Patients
DE Leaf, ED Siew, MF Eisenga, K Singh, FR Causland, A Srivastava, TA Ikizler, LB Ware, AA Ginde, JA Kellum, PM Palevsky, M Wolf, SS Waikar |
Clinical journal of the American Society of Nephrology : CJASN | 2018 |
Acute blood loss stimulates fibroblast growth factor 23 production
S Rabadi, I Udo, DE Leaf, SS Waikar, M Christov |
American journal of physiology. Renal physiology | 2018 |
Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD)
R Vanholder, SV Laecke, G Glorieux, F Verbeke, E Castillo-Rodriguez, A Ortiz |
Toxins | 2018 |
FGF23 Actions on Target Tissues—With and Without Klotho
B Richter, C Faul |
Frontiers in Endocrinology | 2018 |
Cardiotoxicity of Uremic Toxins: A Driver of Cardiorenal Syndrome
S Lekawanvijit |
Toxins | 2018 |
Cardiovascular Interactions between Fibroblast Growth Factor-23 and Angiotensin II
M Pi, R Ye, X Han, B Armstrong, X Liu, Y Chen, Y Sun, LD Quarles |
Scientific Reports | 2018 |
Effects of sucroferric oxyhydroxide and sevelamer carbonate on chronic kidney disease–mineral bone disorder parameters in dialysis patients
M Ketteler, SM Sprague, AC Covic, A Rastogi, B Spinowitz, V Rakov, S Walpen, J Floege |
Nephrology Dialysis Transplantation | 2018 |
The effects of tenapanor on serum fibroblast growth factor 23 in patients receiving hemodialysis with hyperphosphatemia
GA Block, DP Rosenbaum, A Yan, PJ Greasley, GM Chertow, M Wolf |
Nephrology Dialysis Transplantation | 2018 |
Use of phosphate-binders and risk of infection-related and all-cause mortality in patients undergoing hemodialysis: The Q-Cohort Study
S Yamada, M Tokumoto, M Taniguchi, H Yoshida, H Arase, N Tatsumoto, H Hirakata, T Kitazono, K Tsuruya |
Scientific Reports | 2018 |
Exploring the Clinical Relevance of Providing Increased Removal of Large Middle Molecules
M Wolley, M Jardine, CA Hutchison |
Clinical journal of the American Society of Nephrology : CJASN | 2018 |
Fibroblast growth factor 23 does not directly influence skeletal muscle cell proliferation and differentiation or ex vivo muscle contractility
KG Avin, JA Vallejo, NX Chen, K Wang, CD Touchberry, M Brotto, SL Dallas, SM Moe, MJ Wacker |
American journal of physiology. Endocrinology and metabolism | 2018 |
Non-renal-Related Mechanisms of FGF23 Pathophysiology
MR Hanudel, M Laster, IB Salusky |
Current Osteoporosis Reports | 2018 |
Impaired osteocyte maturation in the pathogenesis of renal osteodystrophy
RC Pereira, IB Salusky, P Roschger, K Klaushofer, O Yadin, EG Freymiller, R Bowen, AM Delany, N Fratzl-Zelman, K Wesseling-Perry |
Kidney International | 2018 |
Fibroblast growth factor 23 and α-Klotho co-dependent and independent functions:
LD Quarles |
Current Opinion in Nephrology and Hypertension | 2018 |
Inhibition of fibroblast growth factor 23 (FGF23) signaling rescues renal anemia
R Agoro, A Montagna, R Goetz, O Aligbe, G Singh, LM Coe, M Mohammadi, S Rivella, D Sitara |
The FASEB Journal | 2018 |
Calcitriol downregulates fibroblast growth factor receptor 1 through histone deacetylase activation in HL-1 atrial myocytes
TW Lee, TI Lee, YK Lin, YH Kao, YJ Chen |
Journal of Biomedical Science | 2018 |
Large uremic toxins: an unsolved problem in end-stage kidney disease
MJ Wolley, CA Hutchison |
Nephrology Dialysis Transplantation | 2018 |
Effect of combined vitamin D receptor activator and lanthanum carbonate on serum fibroblast growth factor 23 level in predialysis patients (CVD-LAF study): design and method
E Ito, D Inaguma, S Koide, K Takahashi, H Hayashi, M Hasegawa, Y Yuzawa |
Clinical and Experimental Nephrology | 2018 |
Cardioprotective Effects of Paricalcitol Alone and in Combination With FGF23 Receptor Inhibition in Chronic Renal Failure: Experimental and Clinical Studies
B Czaya, W Seeherunvong, S Singh, C Yanucil, P Ruiz, Y Quiroz, A Grabner, C Katsoufis, S Swaminathan, C Abitbol, B Rodriguez-Iturbe, C Faul, M Freundlich |
American Journal of Hypertension | 2018 |
Effect of Oral Alfacalcidol on Clinical Outcomes in Patients Without Secondary Hyperparathyroidism Receiving Maintenance Hemodialysis: The J-DAVID Randomized Clinical Trial
T Shoji, M Inaba, M Fukagawa, R Ando, M Emoto, H Fujii, A Fujimori, M Fukui, H Hase, T Hashimoto, H Hirakata, H Honda, T Hosoya, Y Ikari, D Inaguma, T Inoue, Y Isaka, K Iseki, E Ishimura, N Itami, C Ito, T Kakuta, T Kawai, H Kawanishi, S Kobayashi, J Kumagai, K Maekawa, I Masakane, J Minakuchi, K Mitsuiki, T Mizuguchi, S Morimoto, T Murohara, T Nakatani, S Negi, S Nishi, M Nishikawa, T Ogawa, K Ohta, T Ohtake, M Okamura, S Okuno, T Shigematsu, T Sugimoto, M Suzuki, H Tahara, Y Takemoto, K Tanaka, Y Tominaga, Y Tsubakihara, Y Tsujimoto, K Tsuruya, S Ueda, Y Watanabe, K Yamagata, T Yamakawa, S Yano, K Yokoyama, N Yorioka, M Yoshiyama, Y Nishizawa |
Journal of the American Medical Association | 2018 |
Targeting Fibroblast Growth Factor 23 Signaling with Antibodies and Inhibitors, Is There a Rationale?
S Fukumoto |
Frontiers in Endocrinology | 2018 |
Association of Fibroblast Growth Factor 23 With Recurrent Cardiovascular Events in Patients After an Acute Coronary Syndrome: A Secondary Analysis of a Randomized Clinical Trial
BA Bergmark, JA Udell, DA Morrow, CP Cannon, DL Steen, P Jarolim, A Budaj, C Hamm, J Guo, KA Im, JF Kuder, E Braunwald, MS Sabatine, ML ODonoghue |
JAMA Cardiology | 2018 |
Physiological Actions of Fibroblast Growth Factor-23
RG Erben |
Frontiers in Endocrinology | 2018 |
Fibroblast growth factor 23 is upregulated in the kidney in a chronic kidney disease rat model
H Sugiura, A Matsushita, M Futaya, A Teraoka, K Akiyama, N Usui, N Nagano, K Nitta, K Tsuchiya, N Ashton |
PloS one | 2018 |
A high-fat diet stimulates fibroblast growth factor 23 formation in mice through TNFα upregulation
P Glosse, A Fajol, F Hirche, M Feger, J Voelkl, F Lang, GI Stangl, M Föller |
Nutrition and Diabetes | 2018 |
Elevated FGF23 Levels in Mice Lacking the Thiazide-Sensitive NaCl cotransporter (NCC)
G Pathare, M Anderegg, G Albano, F Lang, DG Fuster |
Scientific Reports | 2018 |
Effects of erythropoietin on fibroblast growth factor 23 in mice and humans
MR Hanudel, MF Eisenga, M Rappaport, K Chua, B Qiao, G Jung, V Gabayan, B Gales, G Ramos, MA de Jong, JJ van Zanden, MH de Borst, SJ Bakker, E Nemeth, IB Salusky, CA Gaillard, T Ganz |
Nephrology Dialysis Transplantation | 2018 |
The Klotho proteins in health and disease
M Kuro-o |
Nature Reviews Nephrology | 2018 |
Crosstalk between FGF23- and angiotensin II-mediated Ca2+ signaling in pathological cardiac hypertrophy
KN Mhatre, P Wakula, O Klein, E Bisping, J Völkl, B Pieske, FR Heinzel |
Cellular and Molecular Life Sciences | 2018 |
Hyperphosphatemic familial tumoral calcinosis secondary to fibroblast growth factor 23 (FGF23) mutation: a report of two affected families and review of the literature
M Chakhtoura, MS Ramnitz, N Khoury, G Nemer, N Shabb, A Abchee, A Berberi, M Hourani, M Collins, S Ichikawa, GE Fuleihan |
Osteoporosis International | 2018 |
Paracrine Effects of FGF23 on the Heart
M Leifheit-Nestler, D Haffner |
Frontiers in Endocrinology | 2018 |
Impact of Altered Mineral Metabolism on Pathological Cardiac Remodeling in Elevated Fibroblast Growth Factor 23
M Leifheit-Nestler, B Richter, M Basaran, J Nespor, I Vogt, I Alesutan, J Voelkl, F Lang, J Heineke, S Krick, D Haffner |
Frontiers in Endocrinology | 2018 |
Telomere Homeostasis: Interplay with Magnesium
D Maguire, O Neytchev, D Talwar, D McMillan, P Shiels |
International journal of molecular sciences | 2018 |
The Ebb and Flow of Echocardiographic Cardiac Function Parameters in Relationship to Hemodialysis Treatment in Patients with ESRD
C Loutradis, PA Sarafidis, CE Papadopoulos, A Papagianni, C Zoccali |
Journal of the American Society of Nephrology : JASN | 2018 |
Fibroblast Growth Factor 23: A Biomarker of Kidney Function Decline
DA Drew, R Katz, S Kritchevsky, JH Ix, MG Shlipak, AB Newman, A Hoofnagle, L Fried, MJ Sarnak, OM Gutierrez |
American Journal of Nephrology | 2018 |
Increased Circulating FGF23 Does Not Lead to Cardiac Hypertrophy in the Male Hyp Mouse Model of XLH
ES Liu, R Thoonen, E Petit, B Yu, ES Buys, M Scherrer-Crosbie, MB Demay |
Endocrinology | 2018 |
Sleep disordered breathing and fibroblast growth factor 23 in the Hispanic Community Health Study/Study of Latinos
R Mehta, X Cai, A Hodakowski, B Thyagarajan, D Zeng, PC Zee, WK Wohlgemuth, S Redline, JP Lash, M Wolf, T Isakova |
Bone | 2018 |
Vitamin D and kidney disease
L Keung, F Perwad |
Bone Reports | 2018 |
Vitamin D and Calcimimetics in Cardiovascular Disease
K Lim, T Hamano, R Thadhani |
Seminars in Nephrology | 2018 |
Phosphate is a potential biomarker of disease severity and predicts adverse outcomes in acute kidney injury patients undergoing continuous renal replacement therapy
SY Jung, J Kwon, S Park, JH Jhee, HR Yun, HN Kim, YK Kee, CY Yoon, TI Chang, EW Kang, JT Park, TH Yoo, SW Kang, SH Han, YR Kou |
PloS one | 2018 |
Cisplatin nephrotoxicity as a model of chronic kidney disease
M Shi, KL McMillan, J Wu, N Gillings, B Flores, OW Moe, MC Hu |
Laboratory Investigation | 2018 |
The Role of Cardiokines in Heart Diseases: Beneficial or Detrimental?
YS Wu, B Zhu, AL Luo, L Yang, C Yang |
BioMed Research International | 2018 |
FGF23 in Cardiovascular Disease: Innocent Bystander or Active Mediator?
R Stöhr, A Schuh, GH Heine, V Brandenburg |
Frontiers in Endocrinology | 2018 |
Outcome Prediction of Acute Kidney Injury Biomarkers at Initiation of Dialysis in Critical Units
VC Wu, CC Shiao, NH Chi, CH Wang, SC Chueh, HH Liou, H Spapen, PM Honore, TS Chu |
Journal of Clinical Medicine | 2018 |
Dietary Phosphorus and Ambulatory Blood Pressure in African Americans: The Jackson Heart Study
RE Olivo, SL Hale, CJ Diamantidis, NA Bhavsar, CC Tyson, KL Tucker, TC Carithers, B Kestenbaum, P Muntner, RM Tanner, JN Booth, SE Mwasongwe, J Pendergast, LE Boulware, JJ Scialla |
American Journal of Hypertension | 2018 |
Uremic Cardiomyopathy: A New Piece in the Chronic Kidney Disease-Mineral and Bone Disorder Puzzle
PG de Albuquerque Suassuna, H Sanders-Pinheiro, RB de Paula |
Frontiers in Medicine | 2018 |
Fibroblast Growth Factor 23 is Associated With Adiposity in Patients Receiving Hemodialysis: Possible Cross Talk Between Bone and Adipose Tissue
JM Chiang, GA Kaysen, AL Schafer, C Delgado, KL Johansen |
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation | 2018 |
Evidence basis for integrated management of mineral metabolism in patients with end-stage renal disease:
JJ Scialla |
Current Opinion in Nephrology and Hypertension | 2018 |
Fibroblast growth factor23 is associated with axonal integrity and neural network architecture in the human frontal lobes
BK Marebwa, RJ Adams, GS Magwood, M Kindy, J Wilmskoetter, M Wolf, L Bonilha, BC Bernhardt |
PloS one | 2018 |
Chronic kidney disease as a cardiovascular risk factor: lessons from kidney donors
AM Price, NC Edwards, MK Hayer, WE Moody, RP Steeds, CJ Ferro, JN Townend |
Journal of the American Society of Hypertension : JASH | 2018 |
Markers of vitamin D metabolism and incidence of clinically diagnosed abdominal aortic aneurysm: The Atherosclerosis Risk in Communities Study
PL Lutsey, MR Rooney, AR Folsom, ED Michos, A Alonso, W Tang |
Vascular medicine (London, England) | 2018 |
Clinical experience with the use of ferric citrate as a phosphate binder in pediatric dialysis patients
MR Hanudel, M Laster, G Ramos, B Gales, IB Salusky |
Pediatric Nephrology | 2018 |
Uremic Toxins and Clinical Outcomes: The Impact of Kidney Transplantation
S Liabeuf, L Cheddani, Z Massy |
Toxins | 2018 |
High Fibroblast Growth Factor 23 concentrations in experimental renal failure impair calcium handling in cardiomyocytes
M Verkaik, M Oranje, D Abdurrachim, M Goebel, Z Gam, JJ Prompers, M Helmes, PM ter Wee, J van der Velden, DW Kuster, MG Vervloet, EC Eringa |
Physiological Reports | 2018 |
Waist-to-height ratio, body mass index, and cardiovascular risk profile in children with chronic kidney disease
K Sgambat, J Roem, M Mitsnefes, AA Portale, S Furth, B Warady, A Moudgil |
Pediatric Nephrology | 2018 |
Klotho is upregulated in human cardiomyopathy independently of circulating Klotho levels
G Poelzl, SK Ghadge, M Messner, B Haubner, P Wuertinger, A Griesmacher, J Doerler, C Ensinger, H Ulmer, MM Zaruba |
Scientific Reports | 2018 |
Vascular Calcification in Chronic Kidney Disease: The Role of Inflammation
K Benz, KF Hilgers, C Daniel, K Amann |
International Journal of Nephrology | 2018 |
Phosphate and Cardiovascular Disease beyond Chronic Kidney Disease and Vascular Calcification
S Disthabanchong |
International Journal of Nephrology | 2018 |
Role of etelcalcetide in the management of secondary hyperparathyroidism in hemodialysis patients: a review on current data and place in therapy
C Friedl, E Zitt |
Drug design, development and therapy | 2018 |
Fibroblast Growth Factor-23 and Risks of Cardiovascular and Noncardiovascular Diseases: A Meta-Analysis
A Marthi, K Donovan, R Haynes, DC Wheeler, C Baigent, CM Rooney, MJ Landray, SM Moe, J Yang, L Holland, R di Giuseppe, AB Krijger, B Mihaylova, WG Herrington |
Journal of the American Society of Nephrology : JASN | 2018 |
Acute Kidney Injury and Risk of Heart Failure and Atherosclerotic Events
AS Go, C Hsu, J Yang, TC Tan, S Zheng, JD Ordonez, KD Liu |
Clinical journal of the American Society of Nephrology : CJASN | 2018 |
Fibroblast growth factor 23 and Klotho contribute to airway inflammation
S Krick, A Grabner, N Baumlin, C Yanucil, S Helton, A Grosche, J Sailland, P Geraghty, L Viera, DW Russell, JM Wells, X Xu, A Gaggar, J Barnes, GD King, M Campos, C Faul, M Salathe |
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology | 2018 |
Changes in Biomarker Profile and Left Ventricular Hypertrophy Regression: Results from the Frequent Hemodialysis Network Trials
CT Chan, GA Kaysen, GJ Beck, M Li, J Lo, MV Rocco, AS Kliger |
American Journal of Nephrology | 2018 |
Fibroblast Growth Factor‐23 and Heart Failure With Reduced Versus Preserved Ejection Fraction: MESA
MF Almahmoud, EZ Soliman, AG Bertoni, B Kestenbaum, R Katz, JA Lima, P Ouyang, PE Miller, ED Michos, DM Herrington |
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | 2018 |
Intestinal Phosphorus Absorption in Chronic Kidney Disease
E Stremke, KH Gallant |
Nutrients | 2018 |
Serum NGAL and FGF23 may have certain value in early diagnosis of CIN
H Li, Z Yu, L Gan, L Peng, Q Zhou |
Renal Failure | 2018 |
Cardiovascular disease in dialysis patients
M Cozzolino, M Mangano, A Stucchi, P Ciceri, F Conte, A Galassi |
Nephrology Dialysis Transplantation | 2018 |
Letter to the Editor: “Increased Circulating FGF23 Does Not Lead to Cardiac Hypertrophy in the Male Hyp Mouse Model of XLH”
X Han, LD Quarles |
Endocrinology | 2018 |
Left Ventricular Structure in Patients With Mild-to-Moderate CKD—a Magnetic Resonance Imaging Study
MP Schneider, JB Scheppach, U Raff, S Toncar, C Ritter, T Klink, S Störk, C Wanner, G Schlieper, T Saritas, SD Reinartz, J Floege, N Friedrich, R Janka, M Uder, RE Schmieder, KU Eckardt |
Kidney International Reports | 2018 |
Update on Chronic Kidney Disease Mineral and Bone Disorder in Cardiovascular Disease
J Lunyera, JJ Scialla |
Seminars in Nephrology | 2018 |
Quantitative Gadolinium-Free Cardiac Fibrosis Imaging in End Stage Renal Disease Patients Reveals A Longitudinal Correlation with Structural and Functional Decline
TA Stromp, TJ Spear, RM Holtkamp, KN Andres, JC Kaine, WH Alghuraibawi, SW Leung, BK Fornwalt, MH Vandsburger |
Scientific Reports | 2018 |
FGF23 Induction of O-Linked N-Acetylglucosamine Regulates IL-6 Secretion in Human Bronchial Epithelial Cells
S Krick, ES Helton, SB Hutcheson, S Blumhof, JM Garth, RS Denson, RS Zaharias, H Wickham, JW Barnes |
Frontiers in Endocrinology | 2018 |
Changes in serum and intracardiac fibroblast growth factor 23 during the progression of left ventricular hypertrophy in hypertensive model rats
H Fujii, K Watanabe, K Kono, S Goto, S Watanabe, S Nishi |
Clinical and Experimental Nephrology | 2018 |
PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINT
C Ginsberg, TE Craven, MB Chonchol, AK Cheung, MJ Sarnak, WT Ambrosius, AA Killeen, KL Raphael, UY Bhatt, J Chen, GM Chertow, BI Freedman, S Oparil, V Papademetriou, BM Wall, CB Wright, J H., MG Shlipak |
Clinical journal of the American Society of Nephrology : CJASN | 2018 |
Cardiovascular Events after New-Onset Atrial Fibrillation in Adults with CKD: Results from the Chronic Renal Insufficiency Cohort (CRIC) Study
N Bansal, D Xie, D Sha, LJ Appel, R Deo, HI Feldman, J He, K Jamerson, JW Kusek, S Messe, SD Navaneethan, M Rahman, AC Ricardo, EZ Soliman, R Townsend, AS Go |
Journal of the American Society of Nephrology : JASN | 2018 |
Lack of Awareness of Dietary Sources of Phosphorus Is a Clinical Concern
M Shimada, Y Shutto-Uchita, H Yamabe |
In vivo (Athens, Greece) | 2018 |
Active Vitamin D in Chronic Kidney Disease: Getting Right Back Where We Started from?
L Negrea |
Kidney Diseases | 2018 |
Association of Fibroblast Growth Factor 23 With Risk of Incident Coronary Heart Disease in Community-Living Adults
B Panwar, SE Judd, VG Wadley, NS Jenny, VJ Howard, MM Safford, OM Gutiérrez |
JAMA Cardiology | 2018 |
Managing hyperparathyroidism in hemodialysis: role of etelcalcetide
KE Eidman, JB Wetmore |
International journal of nephrology and renovascular disease | 2018 |
Summary of the 2018 ISN Frontiers Meeting: Kidney Disease and Cardiovascular Disease
Kume S, Nagasu H, Nangaku M, Nishiyama A, Nakamoto H, Kashihara N |
Kidney International Reports | 2018 |
Effects of parathyroidectomy on blood bone markers and heart rate variability in patients with stage 5 chronic kidney disease.
Chen H, Cui Y, Xing C, Purrunsing Y, Zha X, Shen C, Zeng M, Yang G, Yu X, Zhang L, Jiang Y, Shen Z, Ma H, Yin C, Li Y, Wang N |
International Urology and Nephrology | 2018 |
Comparison of echocardiographic changes in children with primary hypertension and hypertension due to mild to moderate chronic kidney disease.
Paris G, Gorla SR, Arenas-Morales AJ, Seeherunvong W, Swaminathan S |
Pediatric nephrology (Berlin, Germany) | 2018 |